"Cell Line, Tumor" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A cell line derived from cultured tumor cells.
| Descriptor ID |
D045744
|
| MeSH Number(s) |
A11.251.210.190 A11.251.860.180
|
| Concept/Terms |
Cell Line, Tumor- Cell Line, Tumor
- Cell Lines, Tumor
- Line, Tumor Cell
- Lines, Tumor Cell
- Tumor Cell Lines
- Tumor Cell Line
|
Below are MeSH descriptors whose meaning is more general than "Cell Line, Tumor".
Below are MeSH descriptors whose meaning is more specific than "Cell Line, Tumor".
This graph shows the total number of publications written about "Cell Line, Tumor" by people in this website by year, and whether "Cell Line, Tumor" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2003 | 0 | 18 | 18 |
| 2004 | 0 | 57 | 57 |
| 2005 | 0 | 62 | 62 |
| 2006 | 1 | 57 | 58 |
| 2007 | 0 | 70 | 70 |
| 2008 | 1 | 79 | 80 |
| 2009 | 2 | 105 | 107 |
| 2010 | 0 | 88 | 88 |
| 2011 | 1 | 113 | 114 |
| 2012 | 2 | 90 | 92 |
| 2013 | 2 | 114 | 116 |
| 2014 | 0 | 130 | 130 |
| 2015 | 0 | 136 | 136 |
| 2016 | 0 | 153 | 153 |
| 2017 | 0 | 117 | 117 |
| 2018 | 0 | 143 | 143 |
| 2019 | 1 | 136 | 137 |
| 2020 | 0 | 119 | 119 |
| 2021 | 0 | 118 | 118 |
| 2022 | 0 | 41 | 41 |
| 2023 | 0 | 57 | 57 |
| 2024 | 0 | 98 | 98 |
| 2025 | 0 | 125 | 125 |
| 2026 | 0 | 74 | 74 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cell Line, Tumor" by people in Profiles.
-
CAMKV kinase drives neuroblastoma growth and acts as a novel therapeutic target. J Exp Med. 2026 Oct 05; 223(10).
-
Ceramide-Induced Endoplasmic Reticulum Stress Reveals a Targetable Vulnerability in Endocrine Therapy-Resistant Breast Cancer. Mol Cancer Res. 2026 Sep 02; 24(9):784-800.
-
Targeting Regnase-1 in B7-H3-CAR T cells reprograms the tumor microenvironment and enhances antitumor efficacy for osteosarcoma. Cell Rep Med. 2026 Sep 15; 7(9):103008.
-
ICAM1high Neutrophils Sculpt Tumor Evolution and Metastasis Through Symbiotic Adhesion and Reverse Migration. Cancer Res. 2026 08 14; 86(16):4007-4027.
-
Interfacial lipid digestion-responsive injectable nanoemulsions enhance lapatinib efficacy in triple-negative breast cancer. Colloids Surf B Biointerfaces. 2026 Dec; 268(Pt 2):116079.
-
Targeting oncogenic FLT3 uncovers a ferroptosis vulnerability through selenocysteine recoding in acute myeloid leukaemia. Nat Cell Biol. 2026 Aug; 28(8):1715-1727.
-
Discovery and preclinical activity of the menin-KMT2A inhibitor ziftomenib in acute leukemia models. Blood. 2026 08 06; 148(6):751-766.
-
Development of a structurally distinct TopBP1 inhibitor that enhances PARP blockade and reverses osimertinib resistance. Sci Adv. 2026 Aug 07; 12(32):eaeg1996.
-
Unfolded Protein Response as a Therapeutic Target: 4-(Heptyloxy)phenol Induces Programmed Cell Death in Ewing Sarcoma. Mol Cancer Ther. 2026 Aug 04; 25(8):1342-1356.
-
DNA-FISH Metaphase Spreads to Distinguish Extrachromosomal DNA from Homogeneously Staining Regions in Human Cancer Cell Lines. J Vis Exp. 2026 08 04; (234).